You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Flutemetamol

Showing 1 - 25 of 47
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cardiomyopathies, Primary Trial ((18F)Flutemetamol)

Recruiting
  • Cardiomyopathies, Primary
  • New Haven, Connecticut
    Yale University
Oct 11, 2022

The Swedish BioFINDER - Preclinical AD Study

Recruiting
  • Alzheimer Disease
  • +2 more
  • Plasma tau
  • +4 more
  • Malmö, Sweden
    Skåne University Hospital
Nov 8, 2023

Breast Cancer Trial in Salt Lake City ([18F]Flutemetamol, [18F]fluoro-2-deoxy-D-glucose (FDG), Functional Magnetic Resonance

Recruiting
  • Breast Cancer
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Feb 3, 2022

Regional Cerebral Protein Synthesis in Alzheimer's

Terminated
  • Alzheimer Disease
  • [C11] Leucine PET scan
  • +2 more
  • Manchester, United Kingdom
  • +1 more
Aug 5, 2022

BioFINDER-Brown: Examination of Alzheimer's Disease Biomarkers

Not yet recruiting
  • Alzheimer Disease
  • +2 more
  • Flutemetamol F18 Injection
  • +3 more
  • (no location specified)
Jul 11, 2022

Amyloid Protein and Glucose Metabolism of ALFA Project

Active, not recruiting
  • Alzheimer's Disease
  • 18F-Flutemetamol & 18F-FDG
  • Barcelona, Catalunya, Spain
    BarcelonaBeta Brain Research Center
Jun 8, 2021

Cardiac Amyloidosis Trial in Toulouse (PET with 18 F-Flutemetamol)

Terminated
  • Cardiac Amyloidosis
  • PET with 18 F-Flutemetamol
  • Toulouse, France
    University Hospital Toulouse
Aug 24, 2020

s Requiring Amyloid Positivity With Practice Effects

Recruiting
  • Alzheimer Disease
  • Mild Cognitive Impairment
  • [18F]flutemetamol PET scan
  • Salt Lake City, Utah
    University of Utah
Mar 8, 2021

Cognitive Impairment, Carotid Artery Plaque, Inflammation Trial in Salt Lake City (Imaging with flutemetamol F 18 PET/CT)

Recruiting
  • Cognitive Impairment
  • +2 more
  • Imaging with flutemetamol F 18 PET/CT
  • Salt Lake City, Utah
  • +1 more
Apr 26, 2021

Alzheimer's Disease (AD) and Related Disorders Trial in France (Flutemetamol (18F), Florbetapir (18F))

Completed
  • Alzheimer's Disease (AD) and Related Disorders
  • Flutemetamol (18F)
  • Florbetapir (18F)
  • Angers, France
  • +25 more
Feb 2, 2022

Alzheimer Trial in New York (Escitalopram Pill, Venlafaxine Pill, Placebo Oral Tablet)

Terminated
  • Alzheimer Disease
  • Escitalopram Pill
  • +2 more
  • New York, New York
    New York University School of Medicine
May 29, 2020

Dementia, Alzheimer, Parkinson Disease Trial in Malmö, Ängelholm (Flutemetamol F18 Injection, [18F]-RO6958948, Elecsys (Roche)

Recruiting
  • Dementia
  • +11 more
  • Flutemetamol F18 Injection
  • +3 more
  • Malmö, Sweden
  • +1 more
Feb 28, 2021

Mild Cognitive Impairment, Alzheimer's Disease, Dementia Trial in Schlieren (Flutemetamol (Vizamyl))

Terminated
  • Mild Cognitive Impairment
  • +2 more
  • Flutemetamol (Vizamyl)
  • Schlieren, Zurich, Switzerland
    University of Zurich, Institute for Regenerative Medicine, Cente
Jan 16, 2020

Atherosclerosis Trial in Maastricht (18F-Flutemetamol PET/MRI)

Unknown status
  • Atherosclerosis
  • 18F-Flutemetamol PET/MRI
  • Maastricht, Limburg, Netherlands
    Maastricht University Medical Centre (MUMC+)
Jul 10, 2019

Sleep Apnea, Neurocognitive Decline and Brain Imaging in

Recruiting
  • Obstructive Sleep Apnea
  • +2 more
  • Continuous Positive Airway Pressure or other management for OSA per clinical indications.
  • Hong Kong, Hong Kong
    Queen Mary Hospital
Nov 20, 2023

PET Amyloid Classification Technology

Unknown status
  • Mild Cognitive Impairment
  • +2 more
  • Salt Lake City, Utah
    Center for Alzheimer's Care, Imaging & Research
Jan 24, 2020

Effectiveness of VIZAMYL™ Reader Training Programme in Europe

Completed
  • Cognitive Impairment
    • Linz, Wagner-Jauregg-Weg, Austria
    • +9 more
    Jul 15, 2022

    Preclinical AD: Validation Using Biomarkers

    Completed
    • Mild Cognitive Impairment
      • New York, New York
        NYU Langone Medical Center
      Jan 13, 2021

      OCTA Factors in or Without Amyloid Pathology: A Prospective

      Completed
      • Alzheimer Disease
      • +4 more
        • Busan, Korea, Republic of
          Pusan National University Hospital
        Jul 24, 2022

        Mild Cognitive Impairment, Healthy, Alzheimer Trial in Schlieren (18F-AV-1451 (Tau-PET tracer))

        Active, not recruiting
        • Mild Cognitive Impairment
        • +3 more
        • 18F-AV-1451 (Tau-PET tracer)
        • Schlieren, Zurich, Switzerland
          Institute for Regenerative Medicine (IREM)
        Dec 21, 2021

        Diabetes, Type 1, Diabetes, Type 2, Diabetes, Youth Onset Trial (PI-2620 tracer)

        Not yet recruiting
        • Diabetes Mellitus, Type 1
        • +2 more
        • PI-2620 tracer
        • (no location specified)
        Apr 21, 2022

        Multiple Sclerosis, Inflammatory Disease Trial (PET-MRI with [18F]-Florbetaben and PET-MRI with [18F]-DPA-714)

        Not yet recruiting
        • Multiple Sclerosis
        • Inflammatory Disease
        • PET-MRI with [18F]-Florbetaben and PET-MRI with [18F]-DPA-714
        • (no location specified)
        Jan 10, 2022

        Amyloid-ß Clearance Mechanisms in Alzheimer's Disease

        Recruiting
        • Alzheimer's Disease (AD)
        • positron emission tomography (PET)
        • München, Bayern, Germany
          Klinik und Poliklinik für Psychiatrie und Psychotherapie des LMU
        Sep 16, 2021

        The Swedish BioFINDER - Primary Care Study

        Recruiting
        • Mild Dementia
        • +6 more
        • Plasma APS 2 score
        • +6 more
        • Malmö, Sweden
          Primary care centers in Region Skåne
        Nov 8, 2023

        Cognitive Function and Fatigue After Brain Abscess

        Recruiting
        • Brain Abscess
        • +2 more
        • FDG-PET
        • Oslo, Norway
          Oslo University Hospital
        Sep 27, 2021